Efficacy and safety of adjuvant endocrine therapy in premenopausal patients with early‐stage hormone receptor‐positive breast cancer: A meta‐analysis of randomized controlled trials

Premenopausal Patients ◽

Updated meta-analysis of randomized controlled trials (RCTs) to determine the CDK 4/6 inhibitors associated venous thromboembolism (VTE) risk in hormone receptor-positive breast cancer (BC) patients

Annals of Oncology ◽

10.1093/annonc/mdy300.008 ◽

2018 ◽

Vol 29 ◽

pp. viii606 ◽

Cited By ~ 1

Author(s):

K.Z. Thein ◽

S. Ball ◽

M.H. Zaw ◽

A.M. Tun ◽

M. Quirch ◽

...

Keyword(s):

Breast Cancer ◽

Venous Thromboembolism ◽

Randomized Controlled Trials ◽

Hormone Receptor ◽

Meta Analysis ◽

Controlled Trials ◽

Randomized Controlled ◽

Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials

The Lancet ◽

10.1016/s0140-6736(07)60778-8 ◽

2007 ◽

Vol 369 (9574) ◽

pp. 1711-1723 ◽

Cited By ~ 255

Keyword(s):

Breast Cancer ◽

Adjuvant Treatment ◽

Hormone Receptor ◽

Luteinising Hormone ◽

Individual Patient Data ◽

Meta Analysis ◽

Releasing Hormone ◽

Premenopausal Patients ◽

Efficacy and safety of leuprorelin acetate 6-month depot, TAP-144-SR (6M), in combination with tamoxifen in postoperative, premenopausal patients with hormone receptor-positive breast cancer: a phase III, randomized, open-label, parallel-group comparative study

Breast Cancer ◽

10.1007/s12282-016-0691-6 ◽

2016 ◽

Vol 24 (1) ◽

pp. 161-170 ◽

Cited By ~ 5

Author(s):

Junichi Kurebayashi ◽

Tatsuya Toyama ◽

Shuuji Sumino ◽

Eri Miyajima ◽

Tsukasa Fujimoto

Keyword(s):

Breast Cancer ◽

Hormone Receptor ◽

Phase Iii ◽

Efficacy And Safety ◽

Open Label ◽

Leuprorelin Acetate ◽

Parallel Group ◽

Premenopausal Patients ◽

Anastrozole plus fulvestrant vs. anastrozole alone for hormone receptor-positive advanced breast cancer: a meta-analysis of randomized controlled trials

Breast Cancer Research and Treatment ◽

10.1007/s10549-020-05551-3 ◽

2020 ◽

Vol 180 (2) ◽

pp. 269-278

Author(s):

Meng Li ◽

Yiting Xiong ◽

Chen Liao ◽

Yunyan He ◽

Sijia Duan ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Randomized Controlled Trials ◽

Hormone Receptor ◽

Meta Analysis ◽

Advanced Breast ◽

Controlled Trials ◽

Randomized Controlled ◽

Hormone Receptor Positive

Fulvestrant plus targeted agents versus fulvestrant alone for treatment of hormone-receptor positive advanced breast cancer progressed on previous endocrine therapy: a meta-analysis of randomized controlled trials

Breast Cancer ◽

10.1007/s12282-017-0770-3 ◽

2017 ◽

Vol 24 (3) ◽

pp. 345-352 ◽

Cited By ~ 4

Author(s):

Wen-Zhao Lin ◽

Qi-Ni Xu ◽

Hong-Biao Wang ◽

Xu-Yuan Li

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Randomized Controlled Trials ◽

Endocrine Therapy ◽

Hormone Receptor ◽

Meta Analysis ◽

Controlled Trials ◽

Targeted Agents ◽

Randomized Controlled ◽

Hormone Receptor Positive

Abstract P1-12-02: Effect of using LHRH analog during chemotherapy (CT) on premature ovarian failure and prognosis in premenopausal patients with early-stage, hormone receptor-positive breast cancer: The primary analysis of a randomized controlled phase III trial

10.1158/1538-7445.sabcs14-p1-12-02 ◽

2015 ◽

Cited By ~ 3

Author(s):

Jian-Wei Li ◽

Guang-yu Liu ◽

Ke-Da Yu ◽

Ya-jie Ji ◽

Miao Mo ◽

...

Keyword(s):

Breast Cancer ◽

Early Stage ◽

Phase Iii ◽

Primary Analysis ◽

Phase Iii Trial ◽

Randomized Controlled ◽

Premenopausal Patients ◽

Lhrh Analog ◽

Abstract P3-14-02: Incidence of venous thromboembolism in patients with hormone receptor-positive HER2-negative metastatic breast cancer treated with CDK 4/6 inhibitors: A systematic review and meta- analysis of randomized controlled trials

10.1158/1538-7445.sabcs17-p3-14-02 ◽

2018 ◽

Cited By ~ 2

Author(s):

KZ Thein ◽

MH Zaw ◽

AM Tun ◽

C Jones ◽

S Radhi ◽

...

Keyword(s):

Breast Cancer ◽

Systematic Review ◽

Metastatic Breast Cancer ◽

Venous Thromboembolism ◽

Hormone Receptor ◽

Meta Analysis ◽

Metastatic Breast ◽

Controlled Trials ◽

Randomized Controlled ◽

Hormone Receptor Positive

Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials

Breast Diseases A Year Book Quarterly ◽

10.1016/s1043-321x(08)80059-8 ◽

2008 ◽

Vol 19 (1) ◽

pp. 85

Author(s):

G.F. Fleming ◽

P. Francis

Keyword(s):

Breast Cancer ◽

Adjuvant Treatment ◽

Hormone Receptor ◽

Luteinising Hormone ◽

Individual Patient Data ◽

Meta Analysis ◽

Releasing Hormone ◽

Premenopausal Patients ◽

Concurrent versus sequential adjuvant chemo-endocrine therapy in early stage hormone receptor-positive breast cancer patients: a systematic review and meta-analysis

Annals of Oncology ◽

10.1093/annonc/mdw337.12 ◽

2016 ◽

Vol 27 ◽

pp. iv62

Author(s):

F. Poggio ◽

M. Ceppi ◽

M. Lambertini ◽

P. Bruzzi ◽

D. Ugolini ◽

...

Keyword(s):

Breast Cancer ◽

Systematic Review ◽

Cancer Patients ◽

Endocrine Therapy ◽

Hormone Receptor ◽

Early Stage ◽

Meta Analysis ◽

Breast Cancer Patients ◽

The Examination of Ovarian Reserve in Premenopausal Patients with Hormone Receptor Positive Breast Cancer

The Ewha Medical Journal ◽

10.12771/emj.2017.40.3.104 ◽

2017 ◽

Vol 40 (3) ◽

pp. 104

Author(s):

Hyun-Ah Kim ◽

Joohyun Woo ◽

Hyang Suk Choi ◽

Seok Joon Lee ◽

Jihye Choi ◽

...

Keyword(s):

Breast Cancer ◽

Ovarian Reserve ◽

Hormone Receptor ◽

Premenopausal Patients ◽